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Abstract 
In past numerous medicinal plants had been used for the control of diabetes because 
of their antihyperglycemic effect but there was no scientific proof of it. Aim of current study 
was to evaluate antihyperglycemic and hypolipidemic effect of whole plant of Euphorbia 
prostrata (Family: Euphorbiaceae) in order to validate its traditional use in diabetes, by 
native people of Cholistan desert, Pakistan. Whole plant (methanolic extract) of Euphorbia 
prostrata (EP) (250 and 500 mg/Kg/day, per oral for 14 days) was evaluated in alloxan 
induced diabetic rabbits (150 mg/Kg., i/p.) by serum biochemical parameters. Glibenclamide 
(5 mg/Kg/day, p.o. for 14 days) was used as standard antidiabetic drug. Alloxan induced 
diabetic groups had elevated levels of fasting blood glucose, cholesterol and triglyceride 
levels when compared with control group. EP extract (both doses of 250 and 500 mg/Kg) 
exhibited antidiabetic effect by significant reduction of fasting blood glucose levels. 500 
mg/Kg dose of EP produced more significant (P< 0.05) results as compared to 250 mg/Kg 
dose. Serum cholesterol and triglyceride levels were also lowered doen at the end of study. 
Therefore, outcome of the present study validate the traditional claims on antihyperglycemic 
effects of Euphorbia prostrata (whole plant). 
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Introduction 
Diabetes is one of the major health issues in current scenario and is affecting many 
people from different walks of life in almost every country of the world (Modak et al., 2007). 
Diabetes is a chronic disorder and is associated with abnormal metabolism of carbohydrate, 
fat and protein. Elevated levels of both fasting and post-paradinal blood sugar is the specific 
characteristic of diabetes. Auto-immune and non-auto-immune responses cause destruction of 
pancreatic β-cells resulting in type 1 diabetes (Kanatsuka et al., 2006). There are circulating 
immune markers against pancreatic islets known as anti-islet cell antibodies or β-cell antigens 
(Buchanan and Xiang, 2005). That is the reason for patient’s dependency on external supply 
of insulin but those suffering from Type II diabetes known as non-insulin dependent, can not 
properly respond to insulin. Type II diabetics can be therefore treated by changes in diet 
intake, exercise and by use of medicines. Type II diabetes is more prevalent form among two 
and constitutes about 90% of the whole. Symptoms can be same for both types such as: (i) 
raised levels of blood glucose; (ii) increased need to drink water; (iii) repeated urine output; 
(iv) increased food intake and weight loss; (v) blurred vision; (vi) nausea and vomiting; (vii) 
fatigue and weakness; (viii) restlessness and changes of mood etc. 
Adverse side effects are reported by the use of synthetic oral antidiabetic drugs 
commonly used for the diabetes treatment (Akhtar and Iqbal, 1991) and (Holman and Turner, 
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1991). On the other hand, theses drugs are also not safe during pregnancy (Larner, 1985). In 
recent years, use of herbal origin medicines had grown and these medicines are becoming 
popular in developed as well as developing countries. Natural origin is one of the reasons of 
increased popularity along with low cost and fewer side effects (Modak et al., 2007).  
Medicinal plants are in vogue from many centuries for the management of diabetes 
but very less scientific research had been conducted on these drugs to rule out potentially 
active constituent and their mechanism of action. Euphorbia prostrata commonly known as 
Hazardani is an annual herb, which belongs to family Euphobeaceae and is abundantly found 
in India, Pakistan and Africa (Singla and Pathak, 1990). The dried leaves and seeds are both 
slightly aromatic, and are considered as stimulant, astringent, anthelmintic and laxative. The 
juice from the fresh plant is used to treat ringworm. Among some tribes of India (Nag pur) 
the pounded whole plant, mixed with sugar and water, is used to stop diarrhea. An essential 
oil distilled from the plant is used in medicinal soaps and to treat erysipelas and as a mosquito 
and fly repellent (Parrotta, 2001). 
Several flavonoids like apigenin, quercetin, luteolin (and their glucosides), phenolic 
acids like gallic acid, ellagic acid and tannins are reported to be present in Euphorbia 
prostrata. These active constituents affect the inflammatory process by means of its action on 
the enzymes involved such as cyclooxygenase, protein kinase C, hyaluronidase, 5 –
lipoxigenase, etc, (Wallis, Text Book of Pharmacognosy). The hypoglycemic activity of 
Euphorbia prostrata was reported earlier by Singla and Pathak (1990) but systematic and 
scientific investigations had not been carried out on Euphorbia prostrata. 
Lack of clinical data and scientific research is the main blocking stone in the use of 
herbal origin medicine for the treatment of various illnesses these days. There is continuous 
need of scientific research for proving safety and efficacy of herbal medicines from simple 
biological assays to drug standardization along with toxicity and safety studies. Present study 
was carried out to investigate the antihyperglycemic and hypolipidemic effects of the whole 
plant of E. prostrata in diabetic rabbits.  
 
Material and method 
Chemicals 
All chemicals and drugs of analytical grade were obtained commercially. Alloxan 
monohydrate (98 %) was used to induce diabetes (Acros Organics, USA).Glibenclamide used 
to control diabetes. Commercial kits for the estimation of serum glucose, cholesterol and 
trigycerides were purchased from Human Weisbaden,, Germany.  
 
Plant material and extraction procedure 
Fresh plants of Euphorbia prostrata were collected locally from nearby areas f 
Cholistan desert and were authenticated from Cholistan Institue of Desert Studies, the Islamia 
University of Bahawalpur, Pakistan. A voucher specimen (3402/CIDS/IUB) was deposited in 
the herbarium.   
 
Preparation of Extract 
Plant materials were dried under shade and crushed to get coarse powder. The coarse 
powder (1430 g) was macerated with 70% methanol for 15 days with frequent shaking.  After 
15 days, filteration was carried out through muslin cloth initially and then through Whatman 
filter paper. The filtrate was subjected to evaporation at low temperature (30 to 40 °C) and 
under reduced pressure on rotary evaporator (Heidolph Laborota 4000 efficient, Germany) 
until semisolid residue was obtained. The final extract obtained was in the form of thick 
viscous paste with dark brownish color and approximate yield was 61 g. For convenient 
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administration, the dry extract powder was encapsulated after weighing. Glibenclamid was 
used as a reference antidiabetic agent.  
 
Experimental animals 
Healthy rabbits of either sex (local breed), weighing from 1.5-2 Kg were purchased 
from the local market. They were kept in animal house of Faculty of Pharmacy & Alternative 
Medicine, The Islamia University of Bahawalpur. Standard housing conditions were 
maintained for rabbits and provided standard pellet diet and water ad labitum. All procedures 
were approved prior to performance by Institutional Animals Ethics committee. 
 
Induction of Diabetes 
Diabetes mellitus was induced by intraperitoneal administration of alloxan 
monohydrate (98%) at a dose of 150 mg/kg body weight, dissolvd in normal saline to the 
overnight fasted rabbits. Fasting blood glucose (FBG) level of rabbits was checked up 
regularly for one week to get stable hyperglycemia. Blood glucose level (BGL) was checked 
by Merck microlab 300 (Merck, Germany). Rabbits showing fasting blood glucose level ≥ 
200 mg/dl were destined for screening antidiabetic effects of the crude extract. 
 
Experimental design 
The experimental period was 22 days. The first 8 days were for the induction of 
diabetes in rabbits and the following 14 days were the investigational period with crude 
methanolic extract of Euphorbia prostrata.  
There were five groups of six rabbits each. 
Group-1: Normal saline treated rabbits (Normal control-NC) 
Group-2: Normal saline treated diabetic rabbits (Diabetic Control-DC) 
Group-3: Glibenclamide (5 mg/kg body weight) treated diabetic rabbits (Standard 
Control-SC) 
Group-4: Euphorbia prostrata extract (250 mg/kg/day)) treated diabetic rabbits 
(Euphorbia prostrata crude extract-Ep.Ce 250 mg/kg/day) 
Group-5: Euphorbia prostrata extract (500 mg/kg/day)) treated diabetic rabbits 
(Euphorbia prostrata crude extract-Ep.Ce 500 mg/kg/day) 
 
Blood sampling and biochemical analysis 
Feeding was stopped 12 hrs before blood sampling. Blood samples were drawn at 
the1st, 3rd, 7th and 14th day of study in vacuum tubes without the anticoagulant. Blood was 
centrifuged at 3000 rpm for 10 minutes to separate the serum after which it was tested for 
glucose. At the end of the experimental period (day 14) the blood samples collected were also 
tested for serum cholesterol and triglycerides. Effect of extract was studied up to 6 hours on 
BGL. 
 
Statistical analysis 
Results were presented as the mean standard deviation (SD). A one-way analysis 
variance was performed using SPSS-17 and Graphpad Prism 5 statistical software. Tukey’s 
test was used for comparing the groups. The values were considered significantly different 
when the pvalue was lower than 0.05. 
 
Results 
Antihyperglycemic effect  
The administration of methanolic extract showed a significant reduction in serum 
glucose level in alloxanized rabbits. One week after alloxan administration, serum glucose 
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values were almost 3-folds higher in all diabetic groups as compared to NC group. No 
statistical difference was observed among the diabetic groups before the treatment. Serum 
glucose levels showed a significant reduction in all treatment groups in comparison to the non 
diabetic rats during the experimental period which was more pronounced from the 7th to the 
14th day. After 14 days the blood glucose in the diabetic control still recorded an elevated 
value (table 1).  
Reduction in serum glucose values in diabetic control group was however, non-
significant. When compared to the serum glucose level on day 1 after diabetes induction, 
methanolic extract treatments (250 and 500mg/Kg body weight) showed a significant 
reduction in serum glucose levels over the experimental period comparable with the standard 
drug (Glibenclamide). However, maximal reduction in blood glucose was seen in 500mg/Kg 
body weight over the experimental period (fig. 1). Although the methanolic extract treatments 
(250 and 500mg/Kg body weight) showed a significant (P< 0.05) reduction in serum glucose 
levels as compared to standard drug (table 1). 
Table 1: Effect of Euphorbia prostrata (Ep.Ce) on Fasting Blood Glucose levels (mg/dl) of alloxan induced 
diabetic rabbits 
Effect of Euphorbia prostrata (Ep.Ce) on Fasting Blood Glucose levels (mg/dl) of alloxan induced diabetic 
rabbits 
Sr. 
# Treatment Groups 1
st Day 3rd Day 7th Day 14th Day 
1 Normal Control (N/S 1 ml/Kg) 70.90 ± 3.17 71.01 ± 2.75 70.33 ± 2.52 71.18 ± 2.59 
2 Diabetic Control (N/S 1 ml/Kg) 262.43 ± 7.41 
251.91 ± 
6.08 248.13 ± 6.11 253.38 ± 6.09 
3 Standard Control (Glibenclamide 5 mg/Kg) 
273.15 ± 
6.90 
135.95 ± 
6.08 131.25 ± 3.92 124.16 ± 4.42 
4 Ep.Ce 250 mg/Kg 262.85 ± 2.90 
183.26 ± 
1.19 
180.63 ± 
0.93 
178.21 ± 
0.81 
5 Ep.Ce 500 mg/Kg 269.38 ± 5.16 
166.81 ± 
2.87 
164.45 ± 
2.65 
161.80 ± 
2.55 
 
Fig 1: Effect of Euphorbia prostrata (Ep.Ce) on Fasting Blood Glucose levels (mg/dl) of alloxan induced 
diabetic rabbits 
(N.C = Normal Control, D.C = Diabetic Control, S.C = Standard Control (Glibenclamide 5 mg/Kg) 
 
Values are expressed as Mean ± SEM and n = 6. Tuckey test was used to compare 
means. P values were considered as P < 0.05 as significant (*). Both Extract treated groups 
were compared to positice control, negative control and standard control. 
 
Lipid profile 
Serum lipid levels were measured at the start and end of the experimental time period 
(figs. 2 and 3). Separate tables provided with figs. (2 and 3). The total cholesterol (TC) 
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concentrations of diabetic control rabbits showed a significant increase compared with those 
of the normal control rats. However, rabbits receiving an oral administration of the 
methanolic extracts (250 and 500mg/Kg body weight) and glibenclamide had significantly 
(p<0. 05) lower concentrations of TC comparable to diabetic control group on day 14th at the 
end of experimental period. The administration of the methanolic extracts and the standard 
drug was able to restore and further decrease the total cholesterol which was statistically 
more pronounced (p<0.05) in the groups receiving the methanolic extracts. High dose of 
methanolic extract (500mg/Kg body weight) was significantly better than the low dose 
(250mg/Kg body weight) in restoring the total cholesterol and triglycerides. Thus both doses 
of extract significantly corrected the hypercholesterolemia and hypertriglyceridemia coupled 
with hyperglycemia. 
Table 2: Effect of Euphorbia prostrata (Ep.Ce) on Serum Cholesterol levels (mg/dl) of alloxan induced diabetic 
rabbits 
Effect of Euphorbia prostrata (Ep.Ce) on Serum Cholesterol levels (mg/dl) of alloxan induced diabetic 
rabbits 
Sr. # Treatment Groups 0 Day 14th Day 
1 Normal Control (N/S 1 ml/Kg) 80.70 ± 2.89 81.85 ± 1.79 
2 Diabetic Control (N/S 1 ml/Kg) 145.25 ± 5.54 151.20 ± 3.35 
3 Standard Control (Glibenclamide 5 mg/Kg) 157.63 ± 4.33 100.53 ± 3.19 
4 Ep.Ce 250 mg/Kg 158.73 ± 6.47 134.46 ± 7.94 
5 Ep.Ce 500 mg/Kg 158.28 ± 8.61 126.54 ± 6.95 
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Fig 2: Effect of Euphorbia prostrata (Ep.Ce) on Serum Cholesterol levels (mg/dl) of alloxan induced diabetic 
rabbits 
 
Values are expressed as Mean ± SEM and n = 6. Tuckey test was used to compare 
means. P values were considered as P < 0.05 as significant (*). Both Extract treated groups 
were compared to positice control, negative control and standard control. 
Table 3: Effect of Euphorbia prostrata (Ep.Ce) on Serum Triglyceride levels (mg/dl) of alloxan induced 
diabetic rabbits 
Effect of different doses of Euphorbia prostrata (Ep.Ce) on Serum Triglyceride levels (mg/dl) of 
alloxan induced diabetic rabbits 
Sr. # Treatment Groups 0 Day 14th Day 
1 Normal Control (N/S 1 ml/Kg) 105.70 ± 2.83 108.95 ± 3.20 
2 Diabetic Control (N/S 1 ml/Kg) 167.74 ± 3.56 171.41 ± 2.98 
3 Standard Control (Glibenclamide 5 mg/Kg) 168.80 ± 3.13 101.19 ± 2.17 
4 Ep.Ce 250 mg/Kg 156.14 ± 3.24 129.32 ± 2.59 
5 Ep.Ce 500 mg/Kg 156.36 ± 5.61 123.80 ± 4.32 
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Fig 3: Effect of Euphorbia prostrata (Ep.Ce) on Serum Triglyceride levels (mg/dl) of alloxan induced diabetic 
rabbits 
 
Values are expressed as Mean ± SEM and n = 6. Tuckey test was used to compare 
means. P values were considered as P < 0.05 as significant (*). Both Extract treated groups 
were compared to positice control, negative control and standard control. 
 
Discussion 
Diabetes mellitus is metabolic disorder and its incidence is increasing rapidly 
worldwide. As diabetes is caused by wide variety of factors there is a continuous need to rule 
out different and appropriate ways of treatment to handle this challenging disease (Akah et 
al., 2011). In this regard to establish the scientific basis for utilization of Euphorbia prostrata 
in diabetes management, antihyperglycemic study of methanolic extract was carried out on 
diabetic rabbits. 
Results of current study exhibited a defined role of methanolic extract of Euphorbia 
prostrata plant in reducing serum glucose level in alloxan induced diabetic rabbits. It was 
therefore considered worthwhile to perform antihyperglycemic activity of Ep.Ce. Result of 
current study showed that Ep.Ce decreased serum glucose level in diabetic rabbits. 
Methanolic extract in both doses produced significant (P < 0.05) hypoglycemic effect 6 hours 
after administration but maximum decrease in fasting blood glucose was observed at the dose 
of 500 mg/kg body weight.  Alloxan causes tissue injury of pancreas by production of free 
radicals (Akah et al., 2011). That’s why regeneration of islet beta cell after destruction by 
alloxan is suggested to be the primary mechanism of recovery of alloxan-injected rabbits 
after administration of drugs (Akah et al., 2011). It was also observed that variable dose of 
extract had begun hypoglycemic effect after 2 hours of extract administration. Maximum 
decrease in serum glucose levels was produced at 6th hour after administration of Ep.Ce 
which showed that it takes about 6 hours or even more time for active ingredient(s) of extract 
or its metabolites to enter into circulation and target tissues to bring about glucose lowering 
effect. But the action of Ep.Ce is slower as compared to sulfonylureas and biguanides. Most 
effective dose (500 mg/kg) had closest effect as of synthetic drug glibenclamide.  
It had been reported earlier that treatment with plant origin drugs should be continued 
for longer time duration to get maximum effect (Grover et al., 2000). To get maximum effect 
of Ep.Ce on diabetic rabbits, extract was orally administered once a day for 14 days, the 
period which produced a significant decrease in fasting serum glucose level of diabetic 
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rabbits. Such results confirmed the previous studies that effectiveness of drugs depends on 
the cumulative effect of active principles (Obatomi et al., 1994). Thus, Ep.Ce effectively 
controled serum glucose levels and maintained normal glucose level which can be helpful in 
preventing the microvascular complications related with diabetes. 
In diabetes induced by alloxan there is also increase in serum cholesterol and 
triglyceride levels.  Serum cholesterol and triglycerides levels were brought to near normal by 
the treatment with Ep.Ce in diabetic rabbits. Hypocholestremic and hypotriglyceridemic 
effects can be achieved by tight control over serum cholesterol level. This is in agreement 
with the facts that (1) control of serum glucose is the major determinant of total and very low 
density lipoprotein along with triglyceride levels in blood (Markku Laakso, 1995) and (2) 
better serum glucose control after sulfonyl urea treatment reduces serum VLDL and total 
triglycerides levels( (Huupponen et al., 1984), (Taskinen et al., 1985), (Hughes et al., 
1985) and (Taskinen et al., 1986). The methanolic extract of E. prostrata has hypolipidemic 
effect in addition to antihyperglycemic effect in diabetic rabbits. 
 
Conclusion 
A good control of serum glucose is the cornerstone in the management of diabetes. In 
the present study both doses of E. prostrata exhibited anti-hyperglycemic and hypolipidemic 
activity in alloxan-induced diabetic rabbits. The management of diabetes includes a 
combination of antihyperglycemic drug treatment with lipid-lowering effects. This plant 
could be used as potential therapeutic drugs for the management of diabetes type 2 and 
dyslipidemia associated with it. Further biochemical and pharmacological studies are under 
way to evaluate the mechanism of antihyperglycemic and hypolipidemic activity of E. 
prostrata plant. A long term study however, is imperative as plant products are slow in action 
than the synthetic drugs and at higher doses may also exhibit a plateau effect which would 
not help in diabetes management. 
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